Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Baxter
Pharma
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
AZ executives past and present are under investigation in China. GSK obtained a T-cell engager for lupus. Takeda hit a orexin setback. And more.
Angus Liu
Nov 1, 2024 8:20am
Baxter bolsters IV supplies with imports to address US shortages
Oct 15, 2024 9:50am
Samsung Bio retools $223M production pact with Baxter
Jun 20, 2024 9:36am
FDA slams Eugia with Form 483 and posts several other reprimands
Jan 31, 2024 4:30pm
FDA signs off on Takeda's HyQvia as maintenance therapy for CIDP
Jan 16, 2024 11:12am
Glenmark, Baxter issue recalls for hypertension and cancer drugs
Aug 28, 2023 1:32pm
